当前位置: 首页 >> 检索结果
101. Effectiveness of bevacizumab in the treatment of metastatic colorectal cancer: a systematic review and meta-analysis.
作者: Yu Song.;Qianqian Mao.;Manling Zhou.;Cheng-Jiang Liu.;Li Kong.;Ting Hu.
来源: BMC Gastroenterol. 2024年24卷1期58页
To evaluate the benefit of bevacizumab under the comprehensive treatment strategy and its advantages over other drugs, so as to provide reference for the formulation of clinical plans.
102. Efficacy and safety of the combination of camrelizumab and apatinib in the treatment of liver cancer: a systematic review and single-arm meta-analysis.
To evaluate the efficacy and safety of the combination of camrelizumab and apatinib in the treatment of liver cancer and to furnish clinical recommendations for pharmacological interventions.
103. Not all carotenoids can reduce the risk of gastric cancer: a systematic review with meta-analysis.
Gastric cancer is characterized by high invasiveness, heterogeneity, and late diagnosis, leading to high incidence and mortality rates. It is a significant public health concern globally. Early prevention is crucial in reducing the occurrence of gastric cancer, and dietary prevention, particularly focusing on carotenoids, has been considered a convenient and effective approach. However, the association between carotenoid intake and gastric cancer incidence remains controversial.
104. Predictive value of adipokines for the severity of acute pancreatitis: a meta-analysis.
作者: Xuehua Yu.;Ning Zhang.;Jing Wu.;Yunhong Zhao.;Chengjiang Liu.;Gaifang Liu.
来源: BMC Gastroenterol. 2024年24卷1期32页
Severe acute pancreatitis (SAP) is a dangerous condition with a high mortality rate. Many studies have found an association between adipokines and the development of SAP, but the results are controversial. Therefore, we performed a meta-analysis of the association of inflammatory adipokines with SAP.
105. Efficacy and safety of video-assisted anal fistula treatment in anorectal fistula: a meta-analysis.
作者: Chunqiang Wang.;Tianye Huang.;Xuebing Wang.
来源: Minerva Gastroenterol (Torino). 2023年69卷4期529-536页
By searching relevant literature, the recurrence rate, complication rate after video-assisted anal fistula treatment (VAAFT), and efficacy and safety of the treatment were analyzed.
106. The effectiveness of continuity of care in patients with inflammatory bowel disease: a systematic review.
To investigate the effectiveness of continuity of care in patients with inflammatory bowel disease.
107. Accuracy of the No-Biopsy Approach for the Diagnosis of Celiac Disease in Adults: A Systematic Review and Meta-Analysis.
作者: Mohamed G Shiha.;Nicoletta Nandi.;Suneil A Raju.;Graeme Wild.;Simon S Cross.;Prashant Singh.;Luca Elli.;Govind K Makharia.;David S Sanders.;Hugo A Penny.
来源: Gastroenterology. 2024年166卷4期620-630页
Current international guidelines recommend duodenal biopsies to confirm the diagnosis of celiac disease in adult patients. However, growing evidence suggests that immunoglobulin A (IgA) anti-tissue transglutaminase (tTg) antibody levels ≥10 times the upper limit of normal (ULN) can accurately predict celiac disease, eliminating the need for biopsy. We performed a systematic review and meta-analysis to evaluate the accuracy of the no-biopsy approach to confirm the diagnosis of celiac disease in adults.
108. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022.
作者: Yi-Chu Chen.;Peter Malfertheiner.;Hao-Ting Yu.;Chih-Lin Kuo.;Yung-Yueh Chang.;Fan-Tsui Meng.;Yu-Xuan Wu.;Juo-Lun Hsiao.;Mei-Jyh Chen.;Kun-Pei Lin.;Chun-Ying Wu.;Jaw-Town Lin.;Colm O'Morain.;Francis Megraud.;Wen-Chung Lee.;Emad M El-Omar.;Ming-Shiang Wu.;Jyh-Ming Liou.
来源: Gastroenterology. 2024年166卷4期605-619页
We aimed to assess the secular trend of the global prevalence of Helicobacter pylori (H pylori) infection in adults and children/adolescents and to show its relation to that of gastric cancer incidence.
109. Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm.
作者: Satish S Rao.;Noriaki Manabe.;Yusuke Karasawa.;Yuko Hasebe.;Kazutaka Nozawa.;Atsushi Nakajima.;Shin Fukudo.
来源: BMC Gastroenterol. 2024年24卷1期12页
To comprehensively evaluate the efficacy, safety, patient symptoms, and quality-of-life (QoL) of lubiprostone, linaclotide, and elobixibat as treatment for chronic constipation (CC).
110. Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis.
作者: Ji-Hao Xu.;Chu-Yan Ni.;Yan-Yan Zhuang.;Li Li.;Ying Lin.;Zhong-Sheng Xia.;Wei-Rong Wu.;Qi-Kui Chen.;Wa Zhong.
来源: BMC Gastroenterol. 2023年23卷1期424页
Intraductal papillary mucinous neoplasm (IPMN) is a cystic tumor of the pancreas arising from abnormal papillary proliferation of ductal epithelial cells, and is a precancerous lesion of pancreatic malignancy. This study aimed to evaluate associations between acute pancreatitis (AP) and histologic subtypes of IPMN.
111. Risk factors for metachronous colorectal cancer and advanced neoplasia following primary colorectal cancer: a systematic review and meta-analysis.
作者: Ye Zhang.;Amalia Karahalios.;Ye Kyaw Aung.;Aung Ko Win.;Alex Boussioutas.;Mark A Jenkins.
来源: BMC Gastroenterol. 2023年23卷1期421页
Identifying risk factors for metachronous colorectal cancer (CRC) and metachronous advanced neoplasia could be useful for guiding surveillance. We conducted a systematic review and meta-analysis to investigate risk factors for metachronous CRC and advanced neoplasia.
112. A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma.
To date, an increasing number of studies have revealed that GP73 may have prognostic value in liver cancer. However, most of the studies evaluated serum GP73, and the results regarding the prognostic value of tGP73 in liver cancer are still controversial. Therefore, in this meta-analysis, we aimed to determine whether tGP73 has any prognostic value in patients with HCC.
113. Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis.
Oral nucleoside (acid) analogues (NAs) are recommended for patients with acute-on-chronic liver failure (ACLF) associated with hepatitis B virus (HBV-ACLF). The efficacy and safety of tenofovir (TDF) and entecavir (ETV) in these patients remain unclear.
114. Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis.
作者: Zekun Liu.;Zhenzhen Zhao.;Xuefeng Ma.;Shousheng Liu.;Yongning Xin.
来源: BMC Gastroenterol. 2023年23卷1期384页
Nucleoside analogues are currently applied as a first-line treatment for chronic hepatitis B (CHB) patients. However, the long-term effects of this type of treatment on kidney and bone tissue need to be further investigated.
115. Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis.
Since the previous network meta-analysis assessing the efficacy of prokinetics for functional dyspepsia (FD), there have been a number of new studies and cinitapride is a new prokinetic agent for FD. This updated meta-analysis aimed to explore the efficacy and safety of prokinetics for FD.
116. Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis.
作者: Manesh K Gangwani.;Zohaib Ahmed.;Rizwan Ishtiaq.;Muhammad Aziz.;Anooja Rani.;Dushyant S Dahiya.;Fnu Priyanka.;Syeda F Arif.;Wade Lee-Smith.;Amir H Sohail.;Sumant Inamdar.;Mona Hassan.
来源: Minerva Gastroenterol (Torino). 2024年70卷3期353-358页
Hepatic encephalopathy (HE) after Trans-jugular intrahepatic portosystemic shunt (TIPS) is a common clinical problem. According to recent studies, Proton pump inhibitor (PPI) use can serve as an independent risk factor for HE. We performed a systematic review and meta-analysis to analyze the association between HE with PPI use versus without PPI use in patients undergoing TIPS.
117. Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populations.
作者: Jing Yu.;Yiming Lv.;Peng Yang.;Yizhou Jiang.;Xiangrong Qin.;Xiaoyong Wang.
来源: BMC Gastroenterol. 2023年23卷1期365页
Whether alcohol intake is associated with Helicobacter pylori (H. pylori) eradication failure remains controversial, and this meta-analysis was aimed at investigating the effect of alcohol on the risk of H. pylori eradication failure.
118. Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis.
作者: Xinqiao Chu.;Yaning Biao.;Chengjiang Liu.;Yixin Zhang.;Chenxu Liu.;Ji-Zheng Ma.;Yufeng Guo.;Yaru Gu.
来源: BMC Gastroenterol. 2023年23卷1期346页
Therapeutic options for ulcerative colitis (UC) have increased since the introduction of biologics a few decades ago. Due to the wide range of biologics available, physicians have difficulty in selecting biologics and do not know how to balance the best drug between clinical efficacy and safety. This study aimed to compare the efficacy and safety of biologics in treating ulcerative colitis.
119. Risk factors for the mortality of hepatitis B virus-associated acute-on-chronic liver failure: a systematic review and meta-analysis.
作者: Hanyun Tu.;Rong Liu.;Anni Zhang.;Sufei Yang.;Chengjiang Liu.
来源: BMC Gastroenterol. 2023年23卷1期342页
Hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) has been confirmed as a prevalent form of end-stage liver disease in people subjected to chronic HBV infection. However, there has been rare in-depth research on the risk factors for the mortality of HBV-ACLF. This study aimed at determining the risk factors for the mortality of HBV-ACLF.
120. Accessory hepatic vein recanalization for Budd-Chiari syndrome: a systematic review and meta-analysis.
Budd-Chiari syndrome (BCS) results when the outflow of the hepatic vein (HV) is obstructed. BCS patients exhibiting an accessory HV (AHV) that is dilated but obstructed can achieve significant alleviation of liver congestion after undergoing AHV recanalization. This meta-analysis was developed to explore the clinical efficacy of AHV recanalization in patients with BCS.
|